Today: 7 February 2026
Subscribe
Browse Category

Investment News News 4 February 2026

Eli Lilly stock jumps as 2026 forecast beats estimates on Zepbound, Mounjaro demand

Eli Lilly stock jumps as 2026 forecast beats estimates on Zepbound, Mounjaro demand

Eli Lilly shares surged about 9% Wednesday after reporting a 43% jump in quarterly revenue to $19.3 billion and issuing a bullish 2026 outlook. Mounjaro and Zepbound drove results, but executives warned pricing will weigh on future growth. Investors await the FDA’s April decision on Lilly’s oral obesity drug. The stock’s rally contrasted with declines in major indexes.
4 February 2026
····
CDW stock jumps nearly 10% after earnings beat as AI, cloud demand holds up

CDW stock jumps nearly 10% after earnings beat as AI, cloud demand holds up

CDW shares surged 9.8% to $138.53 after quarterly sales and profit topped estimates, with net sales at $5.51 billion and adjusted earnings of $2.57 per share. Gross profit rose 8.6% and small business sales jumped 18.4%. The board reaffirmed its 2026 growth target. Broader markets fell, with the Nasdaq down 1.53%.
4 February 2026
·····
AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie stock drops after Rinvoq sales miss, even as 2026 profit forecast tops estimates

AbbVie shares fell 2.5% to $219.98 Wednesday after Rinvoq sales missed forecasts, despite the company raising its 2026 profit outlook. Q4 adjusted earnings reached $2.71 per share on $16.618 billion revenue; Skyrizi sales rose 32.5%, while Humira dropped 25.9%. AbbVie announced a three-year Medicaid pact with the Trump administration and pledged $100 billion in U.S. investments.
4 February 2026
·····
Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle stock jumps 11% after earnings beat and $1 billion buyback plan

Carlisle Companies’ shares rose 10.7% to $394 after beating Q4 profit estimates and forecasting low single-digit revenue growth with a 0.50-point margin boost for 2026. Management expects a weak first quarter and flat second quarter, but stronger results in the second half. Q4 revenue was $1.13 billion; adjusted EPS fell to $3.90 from $4.47. The company announced up to $1 billion in buybacks for 2026.
4 February 2026
·····
Home Depot stock climbs as mortgage rates ease and Wall Street looks to Feb. 24 earnings

Home Depot stock climbs as mortgage rates ease and Wall Street looks to Feb. 24 earnings

Home Depot shares rose 1.2% to $385.69 in Wednesday afternoon trading as 30-year mortgage rates slipped to 5.96%, according to NerdWallet. Wolfe Research trimmed its price target by $1 to $414 ahead of the company’s Feb. 24 earnings release. CFO Richard McPhail acquired 144.776 stock units on Jan. 31, per SEC filings.
4 February 2026
·····
CoreWeave stock slides as tech rout deepens; insider sale notices add fresh pressure

CoreWeave stock slides as tech rout deepens; insider sale notices add fresh pressure

CoreWeave shares fell 8.5% to $82.40 Wednesday amid heavy trading, following steep declines in AMD and the Nasdaq. SEC filings showed entities linked to officer Brannin McBee plan to sell over 9,000 shares. Hagens Berman launched a probe into alleged data-center delays and disclosure risks. CoreWeave’s next earnings report is scheduled for Feb. 18.
4 February 2026
······
Goldman Sachs stock slides as Epstein email report dogs the shares — what to know now

Goldman Sachs stock slides as Epstein email report dogs the shares — what to know now

Goldman Sachs shares fell 3.7% to $904.48 after a Reuters report revealed emails showing its chief legal officer, Kathryn Ruemmler, accepted gifts from Jeffrey Epstein and advised him on media matters. The drop outpaced Morgan Stanley and JPMorgan. Ruemmler denied knowledge of Epstein’s crimes. Investors await key U.S. labor and inflation data next week.
4 February 2026
···
AMD stock price slides nearly 17% as AI-chip outlook disappoints; Nvidia and Super Micro in focus

AMD stock price slides nearly 17% as AI-chip outlook disappoints; Nvidia and Super Micro in focus

AMD shares fell nearly 17% after forecasting a sequential revenue decline for the first quarter, despite posting record fourth-quarter sales. Super Micro Computer jumped almost 9% after raising its full-year outlook on strong AI server demand. Nvidia slipped about 4%. Traders are watching Nvidia’s Feb. 25 earnings and a delayed U.S. data release for further direction.
4 February 2026
·······
Cabot (CBT) stock jumps 12% after earnings, battery deal headlines and tire worries linger

Cabot (CBT) stock jumps 12% after earnings, battery deal headlines and tire worries linger

Cabot shares rose 12% to $79.94 after the company tightened its full-year adjusted EPS guidance to $6.00–$6.50. Fiscal Q1 adjusted earnings reached $1.53 per share, while net sales fell to $849 million. Performance Chemicals EBIT increased, driven by battery materials demand, as tire-related volumes stayed weak. Cabot also announced the acquisition of Mexico Carbon Manufacturing from Bridgestone.
4 February 2026
·····
Reynolds Consumer Products stock jumps nearly 15% after Q4 results, steady 2026 outlook

Reynolds Consumer Products stock jumps nearly 15% after Q4 results, steady 2026 outlook

Reynolds Consumer Products shares jumped 14.6% to $25.00 after its Q4 earnings and 2026 outlook. The company reported Q4 net revenues of $1.034 billion and projected 2026 adjusted EBITDA of $660–$675 million, with EPS of $1.57–$1.63. The board approved a $0.23 dividend, payable Feb. 27. Retail revenues slipped, but non-retail sales rose sharply on higher aluminum demand.
4 February 2026
·····
Pfizer stock price jumps as once‑monthly obesity shot data lands; June readout in focus

Pfizer stock price jumps as once‑monthly obesity shot data lands; June readout in focus

Pfizer shares rose 3.7% to $26.73 Wednesday after reporting Phase 2b trial results showing up to 12.3% placebo-adjusted weight loss at 28 weeks for its obesity drug PF’3944. The company reaffirmed its 2026 revenue and profit targets and said it will not pursue share buybacks. Pfizer reported Q4 adjusted EPS of 66 cents on $17.6 billion revenue. Full VESPER-3 results will be released June 6.
4 February 2026
····
Rocket Companies (RKT) stock slides 5% as traders eye Feb. 26 earnings after upbeat mortgage-metrics signal

Rocket Companies (RKT) stock slides 5% as traders eye Feb. 26 earnings after upbeat mortgage-metrics signal

Rocket Companies shares fell 5.2% to $19.29 by midday Wednesday after an SEC filing showed the firm expects its highest fourth-quarter net rate lock volume and gain-on-sale margin since 2021. The company will release full Q4 and 2025 results on Feb. 26. Trading volume Tuesday more than doubled the 50-day average. CEO Varun Krishna said Rocket is on track for its strongest mortgage loan production in four years.
4 February 2026
····
1 … 7 8 9 10 11 … 214

Stock Market Today

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

7 February 2026
Northern Star Resources fell 1.7% to A$26.77 Friday, extending losses as gold miners and the broader market declined. MGX Resources completed its A$50 million purchase of a 50% stake in the Central Tanami Gold Project from Northern Star. The All Ordinaries Gold index dropped 3.24%. CME Group raised COMEX gold futures margin requirements to 9% amid volatility.
PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop